Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Clinical trial NCT00321594 · COMPLETED

Trial details

NCT number: NCT00321594
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adult Primary Hepatocellular Carcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer

Start date: 2006-05-01
Primary completion: 2010-08-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.